共 50 条
[23]
Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis
[J].
JEADV CLINICAL PRACTICE,
2023, 2 (03)
:518-530
[30]
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
[J].
American Journal of Clinical Dermatology,
2023, 24
:753-764